Ester B M Remmerswaal

9PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersInnate immunityAutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
Epithelial PCSK6 Promotes Proliferation and Decreases Collagen Deposition by Fibroblasts Potentially via MMP Activation.

|Mar 03, 2026
Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patients.

Sophie C Frölke, Kenney G Amirkhan, Nelly van der Bom-Baylon

|Jun 28, 2025
HLA-DR expressing lymph node fibroblasts maintain FoxP3+ regulatory T cells and are reduced in rheumatoid arthritis.

Aoife M O'Byrne, Cristoforo Grasso, Charlotte M de Winde

|Feb 04, 2021
CD8 and CD4 T Cell Populations in Human Kidneys.

Carlos van der Putten, Ester B M Remmerswaal, Matty L Terpstra

|Oct 24, 2020
Human CXCR5+ PD-1+ CD8 T cells in healthy individuals and patients with hematologic malignancies.

Tom Hofland, Anne W J Martens, Jaco A C van Bruggen

|Sep 22, 2020
The effect of high-salt diet on t-lymphocyte subpopulations in healthy males-A pilot study.

Eliane F E Wenstedt, Ester B M Remmerswaal, Nelly D van der Bom-Baylon

Pageof 2

Frequent Collaborators

2 joint publications

Arnon P Kater

2 joint publications

Frederike J Bemelman

1 joint publications

Hanspeter Pircher

1 joint publications

Sanne H Tonino